Delivra Health Brands Inc. faced a significant setback in its stock performance, dropping sharply in yesterday's trading session.
Delivra Health Brands Inc. (DHB.V) experienced a steep decline of 17.39% in its stock price yesterday, closing at CA$0.10. This downturn raises questions about the company's market position and future prospects, especially given its relatively small market capitalization of CA$2.97 million.
Investor takeaway: Investors should be cautious, as the significant drop in stock price may indicate underlying issues within the company or market sentiment.
Advertisement
Delivra Health Brands Inc.
DHB.V
DHB.V
Delivra Health Brands Inc.
WealthAwesomeMarket cap
$2.97M
52W high
$0.37
52W low
$0.08
1W change
-13.64%
Beta
0.86
Analyst Price Targets
Based on analyst covering DHB · as of Sep 17, 2026
Wall Street analysts forecast DHB stock price to rise 457.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.53
+457.9% Upside
Current Price
C$0.10
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DHB's historical volatility
30-Day Vol
174.5%
Annualized
90-Day Vol
130.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.09 | C$0.05 – C$0.16 |
| 60 trading days | C$0.08 | C$0.04 – C$0.20 |
| 90 trading days | C$0.08 | C$0.03 – C$0.23 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Bull case
Delivra Health has recently launched new products, including the LivRelief™ Itch Relief Cream. This could help boost sales and improve brand recognition in the health and wellness sector.
Bear case
The sharp decline in stock price suggests that investors are worried about the company's profitability, especially given its negative profit margin of -8.99%.
Market Reaction
Investors reacted sharply to Delivra Health's stock performance, as the 17.39% drop indicates a lack of confidence in the company's current trajectory. With a market cap of only CA$2.97 million, any significant movement in stock price can have an outsized impact on investor sentiment.
Advertisement
Financial Health Concerns
Delivra Health's negative profit margin of -8.99% raises red flags about its financial viability. Without a clear path to profitability, investors may be hesitant to support the stock, leading to further declines in market value.
Future Prospects
While the recent launch of products like LivRelief™ Itch Relief Cream could provide a boost, the company's ability to turn these opportunities into sustainable revenue remains uncertain. Investors will be watching closely for any signs of recovery or further decline.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
